Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | AGPAT2 | O15120 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.37 |
| ▸ | TUBB | P07437 | 1/20 | 0.37 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.37 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.37 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.37 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.37 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.37 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.37 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.37 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.37 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.37 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.37 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL203934 | 0.90 | AGPAT2 (0.47) | ALDH1A1TSHRKMT2AHPGDAGPAT2 | |
| SCHEMBL203542 | 0.89 | CYP1A2 (0.46) | ALDH1A1TSHRKMT2AHPGDAGPAT2 | |
| SCHEMBL203464 | 0.86 | HPGD (0.43) | ALDH1A1TSHRKMT2AHPGDAGPAT2 | |
| SCHEMBL203792 | 0.84 | ALDH1A1 (0.49) | ALDH1A1TSHRKMT2AHPGDAGPAT2 | |
| SCHEMBL203506 | 0.83 | ALDH1A1 (0.60) | ALDH1A1TSHRKMT2AMEN1HTT | |
| SCHEMBL20601875 | 0.76 | HPGD (0.47) | ALDH1A1KMT2AHPGDHTTRAB9A | |
| SCHEMBL202375 | 0.74 | KMT2A (0.58) | ALDH1A1TSHRKMT2AMEN1HTT | |
| SCHEMBL202402 | 0.73 | ALDH1A1 (0.49) | ALDH1A1TSHRKMT2AHPGDAGPAT2 | |
| SCHEMBL203406 | 0.73 | CYP1A2 (0.47) | ALDH1A1TSHRKMT2AHPGDAGPAT2 | |
| SCHEMBL204271 | 0.72 | ALDH1A1 (0.56) | ALDH1A1TSHRKMT2AMEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3746505-B1 | COMPOSITION, POLYMER COMPOSITE ARTICLE FORMED THEREWITH, AND METHOD OF PREPARING SAME | DOW SILICONES CORP (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-3906245-B1 | MULTIFUNCTIONAL ORGANOSILICON COMPOUND AND RELATED METHODS, COMPOUNDS, AND COMPOSITIONS | DOW SILICONES CORP (US) | 2024-05-29 | — | — | EP | disclosed |
| US-20240124709-A1 | COMPOSITION, POLYMER COMPOSITE ARTICLE FORMED THEREWITH, AND METHOD OF PREPARING SAME | DOW GLOBAL TECHNOLOGIES LLC | 2024-04-18 | — | — | US | disclosed |
| EP-3645640-B1 | SILICONE-POLYETHER COPOLYMER, METHOD OF PREPARING SAME, AND SEALANT COMPRISING SAME | DOW SILICONES CORP (US) | 2024-03-06 | — | — | EP | disclosed |
| US-11884821-B2 | Composition, polymer composite article formed therewith, and method of preparing same | DOW SILICONES CORPORATION (US) | 2024-01-30 | — | — | US | disclosed |
| US-11820846-B2 | Composition, method of preparing copolymer, and methods and end uses thereof | DOW SILICONES CORPORATION (US) | 2023-11-21 | — | — | US | disclosed |
| WO-2023215360-A1 | SILICONE-POLYETHER COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORPORATION (US) | 2023-11-09 | — | — | WO | disclosed |
| US-11807775-B2 | Silicone-organic copolymer, sealants comprising same, and related methods | DOW SILICONES CORPORATION (US) | 2023-11-07 | — | — | US | disclosed |
| US-11760841-B2 | Silicone-polycarbonate copolymer, sealants comprising same, and related methods | DOW SILICONES CORPORATION (US) | 2023-09-19 | — | — | US | disclosed |
| EP-3898779-B1 | SILICONE-POLYESTER COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORP (US) | 2023-02-08 | — | — | EP | disclosed |
| EP-1866366-A1 | ORGANOSILOXANE COMPOSITIONS | Dow Corning Corporation (US) | 2007-12-19 | — | — | EP | disclosed |
| EP-1866376-A1 | ORGANOSILOXANE COMPOSITIONS | Dow Corning Corporation (US) | 2007-12-19 | — | — | EP | disclosed |
| WO-2006106359-A2 | ORGANOSILOXANE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2006-10-12 | — | — | WO | disclosed |
| WO-2006106360-A1 | ORGANOSILOXANE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2006-10-12 | — | — | WO | disclosed |
| WO-2006106362-A1 | ORGANOSILOXANE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2006-10-12 | — | — | WO | disclosed |
| WO-2006106095-A1 | ORGANOSILOXANE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2006-10-12 | — | — | WO | disclosed |
| WO-2006106361-A1 | ORGANOSILOXANE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2006-10-12 | — | — | WO | disclosed |
| EP-0585587-B1 | Fungiresistant polyorganosiloxane composition | TOSHIBA SILICONE (JP) | 1997-05-21 | — | — | EP | disclosed |
| US-5378406-A | Benzimidazolylcarbamate, pyridyl oxide zinc salt | TOSHIBA SILICONE CO., LTD. (JP) | 1995-01-03 | — | — | US | disclosed |
| EP-0585587-A1 | Fungiresistant polyorganosiloxane composition | TOSHIBA SILICONE CO., LTD. (JP) | 1994-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11820846-B2 | Composition, method of preparing copolymer, and methods and end uses thereof | BRS3, OXSR1, OXER1 | ALDH1A1 3354/4885TSHR 566/4885KMT2A 4700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.